Chardan Capital Markets Downgrades NeuBase Therapeutics (NBSE) to Neutral

Go back to Chardan Capital Markets Downgrades NeuBase Therapeutics (NBSE) to Neutral
(NASDAQ: NBSE) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High
Open $0.31    52 Week Low
Day High $0.38    P/E N/A 
Day Low $0.38    EPS
Volume 3,292,944